Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/192292
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFernández Deaza, Ginna-
dc.contributor.authorCaicedo Martínez, Maria-
dc.contributor.authorSerrano, Beatriz-
dc.contributor.authorRoura, Esther-
dc.contributor.authorCastillo, Juan Sebastián-
dc.contributor.authorSanjosé Llongueras, Silvia de-
dc.contributor.authorBruni, Laia-
dc.contributor.authorMurillo, Raúl-
dc.date.accessioned2023-01-18T17:48:31Z-
dc.date.available2023-01-18T17:48:31Z-
dc.date.issued2022-07-08-
dc.identifier.issn0036-3634-
dc.identifier.urihttps://hdl.handle.net/2445/192292-
dc.description.abstractObjective. To describe current cervical cancer screening program guidelines in Latin America. Materials and methods. We searched official recommendations for the general population and women living with HIV (WLHIV) by reviewing official sources from 19 countries; these data were supplemented with a consultation carried out by the WHO with the Ministries of Health. Results. Screening policies vary significantly in regard to target populations, primary tests, and screening intervals. Sixteen countries have recently updated their recommendations; however, cytology remains the primary screening test for most countries.Eleven countries have introduced HPV tests, and eight countries have implemented screen-and-treat algorithms; only three countries have developed evidence-based guidelines. All countries but Costa Rica have specific recommendations for WLHIV. Conclusions. Although most countries have updated their screening policies, only a few are properly aligned with the WHO elimination strategy. Recommendations for WLHIV require better integration with cervical cancer screening programs.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherInstituto Nacional de Salud Publica de Mexico-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.21149/13204-
dc.relation.ispartofSalud Pública de México, 2022, vol. 64, num. 4, p. 415-423-
dc.relation.urihttps://doi.org/10.21149/13204-
dc.rightscc by-nc-sa (c) Fernández Deaza, Ginna et al., 2022-
dc.rights.urihttp://creativecommons.org/licenses/by-sa/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationMedicina preventiva-
dc.subject.classificationAmérica latina-
dc.subject.classificationCàncer de coll uterí-
dc.subject.classificationCribratge-
dc.subject.otherPreventive medicine-
dc.subject.otherLatin America-
dc.subject.otherCervix cancer-
dc.subject.otherMedical screening-
dc.titleCervical cancer screening programs in Latin America: current recommendations for facing elimination challenges-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedversion-
dc.date.updated2023-01-16T09:39:21Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid36130384-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
13204-Texto del artículo-64557-2-10-20220711.pdf437.94 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons